This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.


About PATH Center for Vaccine Innovation and Access

The PATH Center for Vaccine Innovation and Access (CVIA) works to develop and deliver lifesaving vaccines to women, children, and communities around the globe.

Vaccines are one of the most successful, cost-effective solutions available to ensure children, no matter where they’re born, not only survive, but can thrive and reach their full potential. That’s why we work to accelerate the development and introduction of lifesaving vaccines around the world.

Our portfolio encompasses more than two dozen vaccine projects either in development or already in use to protect against 17 different diseases, with an emphasis on the world’s leading infectious causes of childhood deaths such as diarrheal disease, pneumonia and malaria. CVIA builds on more than 20 years of PATH’s success in developing and delivering vaccines to improve health for the most vulnerable populations, in some of the hardest to reach places.

But it takes a lot to move a vaccine from an idea into a safe and effective tool used to prevent disease. It's even more challenging when the diseases disproportionately impact young children and women in low-resource settings. At CVIA, we bring together expertise across the entire vaccine development and delivery spectrum – from early-stage research to innovative approaches for new vaccine introduction and everything in between.

We also forge deep collaboration with multiple partners, including immunization program managers and ministries of health to provide crucial insights; with scientists and clinical researchers to develop and evaluate novel approaches to vaccines in real-world conditions; with manufacturers to accelerate development; global agencies like the World Health Organization and UNICEF; financing bodies like Gavi, the Vaccine Alliance; and governments to support immunization implementation. We work with communities to understand their needs and priorities, and commit to pricing and distribution strategies that ensure accessibility, availability, affordability, acceptability, and sustainability.

CVIA projects are currently supported by grants from numerous funders, including the Bill & Melinda Gates Foundation, the US Department of Health and Human Services, and the United Kingdom’s Department for International Development. Some projects in CVIA are funded by PATH Vaccine Solutions (PVS) – an affiliate nonprofit corporation with 501(c)(3) tax-exempt status and a supporting organization of PATH. The PVS board of directors is chaired by the PATH president and CEO.

Meet the CVIA team

  1. Dr. David Kaslow

    Vice President, Essential Medicines. Director, Center for Vaccine Innovation and Access

  2. Jessica Milman

    Director, Office of Essential Medicines

  3. Terri Ebert

    Global Human Resources Director, Essential Medicines

  4. Dr. Bruce Innis

    Global Head, Respiratory Infections & Maternal Immunization, CVIA

  5. Dr. Ashley Birkett

    Global Head, Malaria, Center for Vaccine Innovation and Access

  6. Dr. Fred Cassels

    Global Head, Enteric and Diarrheal Diseases, Center for Vaccine Innovation and Access

  7. Dr. Debbie Atherly

    Global Head, Policy Access and Introduction, Center for Vaccine Innovation and Access

  8. Dr. Jorge Flores

    Global Head, Clinical and Regulatory Affairs, Center for Vaccine Innovation and Access

  9. Dr. John Konz

    Leader, Integrated Portfolio and Financial Management, Center for Vaccine Innovation and Access

  10. Katya Spielberg

    Global Head, Finance and Contract Management, Center for Vaccine Innovation and Access

  11. Dr. Margaret Wecker

    Global Head, Regulatory, Center for Vaccine Innovation and Access

  12. Darin Zehrung

    Program Leader, Medical Devices and Health Technologies